Neuroleptic-induced oral movements in rats: methodological issues
- PMID: 2887997
- DOI: 10.1016/0024-3205(87)90715-6
Neuroleptic-induced oral movements in rats: methodological issues
Abstract
In three separate experiments groups of rats were chronically administered neuroleptics in a variety of ways (chronic injections, subcutaneous implants, and decanoate injections) and examined for oral movements (OMs) in two different tests: in an open cage using a human observer, or in a plexiglas tube enclosure, where OMs were monitored both by a human observer and computerized video analysis system. These two testing methods showed different effects of neuroleptic administration. In the open cage, OMs tended to be enhanced during chronic neuroleptic exposure and to rapidly subside upon drug withdrawal. The enhanced OMs were especially present just after drug injections, when activity levels were low. In the observation tube environment, however, OMs tended to be low soon after drug treatments, and elevated upon withdrawal. Thus, the type of behavioral test used determines how neuroleptic-induced increases in oral activity should be interpreted.
Similar articles
-
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.Psychopharmacology (Berl). 1988;94(3):421-7. doi: 10.1007/BF00174701. Psychopharmacology (Berl). 1988. PMID: 3128820
-
Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats.Psychopharmacology (Berl). 1988;96(2):253-7. doi: 10.1007/BF00177570. Psychopharmacology (Berl). 1988. PMID: 2906749
-
Tremorous mouth movements in rats administered chronic neuroleptics.Psychopharmacology (Berl). 1987;92(1):122-6. doi: 10.1007/BF00215492. Psychopharmacology (Berl). 1987. PMID: 2885880
-
[Neuroleptic-induced movement disorders: historical perspectives].Encephale. 1993 Nov-Dec;19(6):657-61. Encephale. 1993. PMID: 12404786 Review. French.
-
The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia.Mov Disord. 1993 Oct;8(4):445-52. doi: 10.1002/mds.870080405. Mov Disord. 1993. PMID: 7901759 Review.
Cited by
-
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.Psychopharmacology (Berl). 1988;94(3):421-7. doi: 10.1007/BF00174701. Psychopharmacology (Berl). 1988. PMID: 3128820
-
Drug-induced purposeless chewing: animal model of dyskinesia or nausea?Psychopharmacology (Berl). 1990;102(3):325-8. doi: 10.1007/BF02244098. Psychopharmacology (Berl). 1990. PMID: 1979178
-
Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.Psychopharmacology (Berl). 1995 Feb;117(4):403-12. doi: 10.1007/BF02246211. Psychopharmacology (Berl). 1995. PMID: 7604140
-
Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.Psychopharmacology (Berl). 1990;100(3):404-12. doi: 10.1007/BF02244615. Psychopharmacology (Berl). 1990. PMID: 2315437
-
Effects of CATECHIN on reserpine-induced vacuous chewing movements: behavioral and biochemical analysis.Naunyn Schmiedebergs Arch Pharmacol. 2020 Dec;393(12):2439-2452. doi: 10.1007/s00210-020-01923-0. Epub 2020 Jul 29. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 32725283
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources